Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle

Roche launches spinal muscular atrophy treatment drug in India priced at around Rs 6 lakh per bottle The drug is approved for the treatment of SMA in adults and children 2 months of age and older, Roche said adding that it was approved by the Indian health authorities after reviewing its efficacy and safety data from three global clinical studies designed to represent a broad spectrum of people living with SMA. https://ift.tt/eA8V8J